Not intended for contact lens-related irritation. Pregnancy and lactation. Remove contact lenses prior to eye admin. Reinsert contact lenses 10 min after admin. Do not wear contact lenses if eyes are red. Improper handling may contaminate soln w/ bacteria that may cause ocular infections. Tip of the dispensing container should not be in contact w/ eye, eyelids or surrounding structures. Monitoring Parameters.
Lactation: Unknown if distributed into breast milk; use caution
Indication
Allergic conjunctivitis
Contra Indication
It is contraindicated incase of hypersensitivity to Olopatadine or to any component of the preparation.
Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks
Mode of Action
Olopatadine is a relatively selective histamine H1-receptor antagonist which inhibits the release of histamine from mast cells and histamine-induced effects on conjunctival epithelial cells. It shares many of the pharmacologic effects of mast cell stabilisers.
Interaction
May result in additive CNS depression w/ CNS depressants.
Pregnancy Category Note
N/A
Adult Dose
Adults: 1 drop in the conjunctival sac of the affected eye(s) twice daily at an interval of 6-8 hr.
Child Dose
Children (above 3 years of age). 1 drop in the conjunctival sac of the affected eye(s) twice daily at an interval of 6-8 hr.
Renal Dose
N/A
Administration
N/A
Disclaimer
The information provided herein are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please note that this information should not be treated as a replacement for physical medical consultation or advice. Great effort has been placed to provide accurate and comprehensive data. However, Medicart along with its authors and editors make no representations or warranties and specifically disclaim all liability for any medical information provided on the site. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company.